Cachexia - sarcopenia as a determinant of disease control rate and survival in non-small lung cancer patients receiving immune-checkpoint inhibitors
Benoît Roch, Amandine Coffy, Sandy Jean-Baptiste, Estelle Palaysi, Jean‐Pierre Daurès, Jean-Louis Pujol, Sébastien Bommart
Topics & Concepts
CachexiaSarcopeniaMedicineInternal medicineOncologyHazard ratioLung cancerProportional hazards modelCancerOdds ratioConfidence intervalNutrition and Health in AgingMuscle Physiology and DisordersFrailty in Older Adults